(2003). Genomic Capital: Public Cultures and Market Logics of Corporate Biotechnology. Science as Culture: Vol. 12, No. 1, pp. 87-121.
No takes yet. Share an insight, caveat, or question.
Kaushik Sunder Rajan (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: